A1 Refereed original research article in a scientific journal

CC chemokine ligand 2 (CCL2) stimulates aromatase gene expression in mammary adipose tissue




AuthorsMartínez-Chacón Gabriela, Yatkin Emrah, Polari Lauri, Dinç Deniz D, Peuhu Emilia, Hartiala Pauliina, Saarinen Niina, Mäkelä Sari

Publication year2021

JournalFASEB Journal

Journal name in sourceFASEB journal : official publication of the Federation of American Societies for Experimental Biology

Journal acronymFASEB J

Article numbere21536

Volume35

Issue5

ISSN0892-6638

eISSN1530-6860

DOIhttps://doi.org/10.1096/fj.201902485RRR

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/56035334


Abstract
Obesity is a risk factor for postmenopausal breast cancer. Obesity-related inflammation upregulates aromatase expression, the rate-limiting enzyme for estrogen synthesis, in breast adipose tissue (BAT), increasing estrogen production and cancer risk. The regulation of aromatase gene (CYP19A1) in BAT is complex, and the mechanisms linking obesity and aromatase dysregulation are not fully understood. An obesity-associated factor that could regulate aromatase is the CC chemokine ligand (CCL) 2, a pro-inflammatory factor that also activates signaling pathways implicated in CYP19A1 transcription. By using human primary breast adipose stromal cells (ASCs) and aromatase reporter (hARO-Luc) mouse mammary adipose explants, we demonstrated that CCL2 enhances the glucocorticoid-mediated CYP19A1 transcription. The potential mechanism involves the activation of PI.4 via ERK1/2 pathway. We also showed that CCL2 contributes to the pro-inflammatory milieu and aromatase expression in obesity, evidenced by increased expression of CCL2 and CYP19A1 in mammary tissues from obese hARO-Luc mice, and subcutaneous adipose tissue from obese women. In summary, our results indicate that postmenopausal obesity may promote CCL2 production in BAT, leading to exacerbation of the menopause-related inflammatory state and further stimulation of local aromatase and estrogens. These results provide new insights into the regulation of aromatase and may aid in finding approaches to prevent breast cancer.

Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 20:52